Auro-Dapagliflozin 10 mg (Dapagliflozin TABLET) 10 MG

Auro-Dapagliflozin 10 mg is used to manage conditions related to glucose regulation and cardiovascular health. It is primarily indicated for the following conditions:

• Type 2 diabetes mellitus: Helps lower blood sugar levels in adults with type 2 diabetes when combined with diet and exercise.
• Heart failure with reduced ejection fraction: Improves heart function and reduces the risk of hospitalization in patients with heart failure.
• Chronic kidney disease: Helps manage and slow the progression of kidney disease in adults with type 2 diabetes.

• Auro-Dapagliflozin 10 mg works by inhibiting the sodium-glucose cotransporter 2 (SGLT2) in the proximal renal tubules. This inhibition reduces the reabsorption of glucose, increasing its excretion through urine. By promoting the removal of excess glucose, the medication helps lower blood sugar levels in patients with type 2 diabetes, heart failure, and chronic kidney disease.

Auro-Dapagliflozin 10 mg may cause various side effects, which can be categorized as common or serious.

Common Side Effects

• Increased urination: Helps remove excess glucose from the body.
• Thirst: Due to increased urine output.
• Dizziness: May occur as a result of changes in blood sugar levels.
• Fatigue: Can be a result of the body's adjustment to lower blood sugar levels.

Serious or Rare Side Effects

• Urinary tract infections: Increased risk due to higher glucose levels in urine.
• Hypoglycemia: Low blood sugar levels, especially when combined with other diabetes medications.
• Dehydration: Due to increased urination, it is important to stay hydrated.
• Kidney problems: May affect kidney function, particularly in patients with pre-existing kidney issues.

Auro-Dapagliflozin 10 mg should be used with caution and under the guidance of a healthcare provider. Important precautions include:

• Kidney function: Regular monitoring is essential, especially in patients with kidney issues.
• Urinary tract infections: Increased risk due to higher glucose levels in urine; seek medical advice if symptoms occur.
• Dehydration: Stay hydrated to prevent complications from increased urination.
• Hypoglycemia: Monitor blood sugar levels, especially when combined with other diabetes medications.
• Pregnancy: Consult a healthcare provider before use, as safety during pregnancy has not been established.
• Store below 25°C: Keep in the original pack, protect from moisture.

Auro-Dapagliflozin 10 mg may interact with other medications, which can be categorized as major or moderate interactions.

Major Interactions (Avoid)

• Insulin: Increased risk of hypoglycemia; close monitoring is required.
• Other SGLT2 inhibitors: Avoid concurrent use to prevent additive effects.
• Diuretics: May increase the risk of dehydration and electrolyte imbalances.

Moderate Interactions (Monitor Closely)

• ACE inhibitors: May affect kidney function; regular monitoring is advised.
• Beta-blockers: May mask symptoms of hypoglycemia; monitor blood sugar levels closely.
• Nonsteroidal anti-inflammatory drugs (NSAIDs): May affect kidney function; use with caution.